Clinical trial
Transplant and Addiction Project (TAP) - 1
NCT00249652 · St. Luke's-Roosevelt Hospital Center, Other · Completed
Key facts
| NCT number | NCT00249652 |
|---|---|
| Title | Transplant and Addiction Project (TAP) - 1 |
| Official title | Drug Treatment for Transplant Candidates |
| Lead sponsor | St. Luke's-Roosevelt Hospital Center, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | End Stage Liver Disease, End Stage Renal Disease, Substance-Related Disorders |
| Intervention type | Behavioral, Other |
| Interventions | TAP, TAU |
| Enrollment | 41 |
| Start date | Sep 1, 2003 |
| Primary completion | Jun 1, 2009 |
| Completion | Sep 1, 2009 |
| First posted | Nov 7, 2005 |
| Last update posted | Apr 14, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: